APA (7th ed.) Citation

Jahn, U., Garske-Román, U., Sandström, M., Lubberink, M., & Sundin, A. (2023). Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression. EJNMMI Research, 13(1), 1. https://doi.org/10.1186/s13550-023-00997-0

Chicago Style (17th ed.) Citation

Jahn, Ulrika, Ulrike Garske-Román, Mattias Sandström, Mark Lubberink, and Anders Sundin. "Impact of Administered Amount of Peptide on Tumor Dosimetry at the First Cycle of Peptide Receptor Radionuclide Therapy (PRRT) in Relation to Total Tumor Somatostatin Receptor Expression." EJNMMI Research 13, no. 1 (2023): 1. https://doi.org/10.1186/s13550-023-00997-0.

MLA (9th ed.) Citation

Jahn, Ulrika, et al. "Impact of Administered Amount of Peptide on Tumor Dosimetry at the First Cycle of Peptide Receptor Radionuclide Therapy (PRRT) in Relation to Total Tumor Somatostatin Receptor Expression." EJNMMI Research, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1186/s13550-023-00997-0.